Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$56.27 - $73.77 $19,075 - $25,008
339 Added 12.33%
3,088 $213,000
Q4 2023

Feb 15, 2024

BUY
$59.06 - $75.72 $162,355 - $208,154
2,749 New
2,749 $203,000
Q2 2023

Aug 07, 2023

BUY
$62.68 - $95.05 $142,597 - $216,238
2,275 New
2,275 $213,000
Q3 2018

Nov 13, 2018

SELL
$48.29 - $80.6 $7,050 - $11,767
-146 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$37.84 - $69.96 $1,892 - $3,497
50 Added 52.08%
146 $9,000
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $3,822 - $5,522
96 New
96 $4,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Midwest Professional Planners, Ltd. Portfolio

Follow Midwest Professional Planners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.